Eliminating Central Line Associated Bloodstream Infections in Pediatric Oncology Patients: A Quality Improvement

Daniel N Willis1, Karen Looper2, Rema A Malone3

  • 1From the Department of Pediatrics, Division of Hematology/Oncology, Washington University School of Medicine, St. Louis Children's Hospital, St. Louis, Mo.

PubMed

Insights

Pediatric hematology/oncology patients experienced a 50% reduction in Central Line-Associated Bloodstream Infections (CLABSI). This was achieved through a multimodal approach, significantly improving patient safety and reducing infection rates.

Area of Science:

  • Healthcare quality improvement
  • Infection control in pediatric oncology

Background:

  • Central Line-Associated Bloodstream Infections (CLABSI) are a significant cause of harm in pediatric hematology/oncology (PHO) patients.
  • Traditional prevention strategies are often insufficient for this high-risk population.

Purpose of the Study:

  • To reduce the CLABSI rate by 50% in PHO patients from a baseline of 1.89/1000 central line days to <0.9/1000 by December 31, 2021.
  • Implement and evaluate targeted interventions for CLABSI prevention in a high-risk pediatric population.

Main Methods:

  • Established a multidisciplinary team with defined roles and responsibilities.
  • Developed a key driver diagram to guide intervention design and implementation.
  • Utilized Plan-Do-Study-Act cycles and direct observation audits for accurate compliance assessment.

Main Results:

  • Achieved a CLABSI rate of 0.73/1000 central line days in 2021, a reduction from 1.89/1000 in 2020.
  • Increased average days between CLABSI events from 30 to 73 days.
  • Attained 542 consecutive CLABSI-free days, extending into 2022.

Conclusions:

  • A multimodal approach, incorporating high-reliability organization principles, significantly reduced CLABSI in PHO patients.
  • Sustained engagement and a strong safety culture are crucial for maintaining reduced infection rates.
  • The study demonstrated a successful strategy for approaching zero CLABSI in a vulnerable pediatric population.

Related Concept Videos

Parentral Nutrition: Centeral and Peripheral Parental Nutrition01:27

Parentral Nutrition: Centeral and Peripheral Parental Nutrition

Parenteral Nutrition (PN) delivers essential nutrients directly into the bloodstream, bypassing the digestive system. It is commonly used for individuals with severe digestive disorders or conditions that prevent normal nutrient absorption.
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
232
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
2.7K
Endocarditis IV: Nursing Management01:29

Endocarditis IV: Nursing Management

Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...
16
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
364
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
1.3K